ADC Therapeutics SA Balance Sheet
ADCT|3 years of annual SEC 10-K data (FY2023-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 3 fiscal years. All figures from audited SEC 10-K filings.
ADC Therapeutics SA had $323M in total assets with negative shareholders' equity of $186M as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -4.83 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Cash & Equivalents | $261.3M | $250.9M | $278.6M |
| Inventory | $4.2M | $18.4M | $16.2M |
| Current Assets | $306.3M | $307.4M | $336.3M |
| PP&E (Net) | $0 | $5.1M | $5.6M |
| Total Assets | $323.1M | $322.0M | $354.8M |
| Current Liabilities | $70.2M | $80.5M | $67.7M |
| Shareholders' Equity | -$185.8M | -$148.2M | $79.5M |